Navigation Links
Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
Date:5/8/2008

VYVANSE demonstrated significant improvement in ADHD symptoms in adults

WASHINGTON, May 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints.

"Adults with ADHD often find it challenging to focus and organize during the day. The disorder may impact many aspects of their lives from career to family and personal commitments," said Lenard A. Adler, M.D., lead researcher in this study and director of the Adult ADHD program at the NYU Langone Medical Center, associate professor of psychiatry, neurology and child and adolescent psychiatry at the New York University School of Medicine, as well as author of Scattered Minds: Help and Hope for Adults with ADHD (G. P. Putnam's Sons 2006). "This study demonstrated that VYVANSE significantly improved ADHD symptoms in adults, including inattention, such as the ability to focus, organize and complete tasks, which are essential during an adult day, as well as hyperactivity, such as restlessness, and impulsivity."

This double-blind, placebo-controlled, four-week, forced-dose study in 414 adults aged 18 to 55 years showed that treatment with VYVANSE at all doses studied (30 mg, 50 mg, 70 mg) provided a significant reduction in ADHD Rating Scale (ADHD-RS-IV) scores within one week that were observed throughout the full treatment period. At endpoint, VYVANSE demonstrated a significant improvement in ADHD symptoms, based on a 43 percent reduction in ADHD-RS scores. This is the largest placebo-controlled stimulant trial of ADHD in adults conducted to date.

Additional Study Findings

Investigators also measured the efficacy of VYVANSE with the Clinical Global Impressions-Improvement (CGI-I) scale and found that the percent
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- Dr. Davis Lee , CMIO for PIH ... the 2013 AMDIS Award, a prestigious recognition saluting excellence ... "On behalf of Allscripts, I,d like to congratulate ... continuous efforts to improve patient care and population health," ... Executive Officer of Allscripts. "We are committed to our ...
(Date:6/19/2013)... 19, 2013 The American Association for Homecare (AAHomecare), ... Maryland , announced today the filing of a ... D.C. , asking that the scheduled July 1 expansion ... equipment (DME) be stopped because of serious licensing irregularities. ... Services (HHS) Secretary Kathleen Sebelius as the ...
(Date:6/19/2013)... THOUSAND OAKS, Calif. , June 19, 2013 ... the United States , Canada ... are this year,s recipients of the Amgen Award for Science ... recognizes extraordinary teachers at the kindergarten through 12th grade level ... results in science education. With a long-standing commitment ...
Breaking Medicine Technology:Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3
... 17, 2011 Surgical Information Systems ("SIS") announced ... information management systems as a key component of ... the Healthcare Information and Management Systems Society, February ... industry presentations and solution demonstrations, SIS will showcase ...
... Therapeutics, Inc., a developer of novel lumbar spine anulus ... first patient, December 17, 2010, in a Randomized Clinical ... prevent reherniations following lumbar discectomy, while allowing the surgeon ... possible preserving normal disc height and biomechanics. Barricaid accomplishes ...
Cached Medicine Technology:Surgical Information Systems Focuses on Surgery and Anesthesia as a Key Component of the EHR at HIMSS11 2Surgical Information Systems Focuses on Surgery and Anesthesia as a Key Component of the EHR at HIMSS11 3Intrinsic Enrolls First Patient in Barricaid® Trial 2
(Date:6/20/2013)... Millions of Britons are risking ... because they do not brush their teeth every day, ... , Seven million Britons do not clean their teeth ... latest data from the British Dental Health Foundation shows. ... the BDHF also admitted that they forgot to floss ...
(Date:6/20/2013)... In an article found on Science ... can show similarities between an addiction to drugs, and ... current global obesity pandemic. , To test the hypothesis ... one can be addicted to drugs, Dr Francesco Leri, ... the University of Guelph, has studied the effects of ...
(Date:6/20/2013)... 20, 2013 Creighton University ... Service Honor Roll – the highest federal recognition a ... volunteering, student- service learning and civic engagement as well ... the Corporation for National and Community Service, is given ... Creighton. “Our foundation at Creighton is based on spiritual ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 Everyone is looking for ... and inexpensive way to do so. It is called Skin ... - only 5 minutes per day - to improve health and ... improves general health. How? , Skin Brushing improves general health ... it aids the lymphatic system to drain toxins , ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 Shreya Rangarajan ... the global youth summit on the future of medicine. ... to the Global Youth Summit on the Future of ... Park Country School and the state of Maryland at ... providers will practice in an environment hard to imagine ...
Breaking Medicine News(10 mins):Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 3
... the U.S. Food,and Drug Administration (FDA) approved Abbott,s TRILIPIX(TM) ... help lower triglycerides,and LDL cholesterol, and to raise HDL ... first and only fibrate to be approved for use ... guidelines,recommend the combination of a fibrate with a statin ...
... 15 Two leading cancer physicians and,researchers affiliated with ... Antonio Breast Cancer Symposium. Three others presented their,research in ... 14. , Dr. ... its breast,cancer research committee, presented findings on the largest ...
... role in immune, inflammatory processes, study says , , ... have higher levels of the obesity-related hormone leptin than ... study included 77 psoriasis patients and a control group ... researchers gathered health information about the participants and analyzed ...
... to Controlling Costs, Improving Quality as Health Care Reform Debate Centers ... WASHINGTON, Dec. 15 House Ways and Means Health Subcommittee Chairman ... senior counsel to Sen. Max Baucus, will join health care expert ... America,s Future co-director Roger Hickey on a conference call ...
... first piece of DNA luxury jewellery will be sold,at ... be used to finance the,anti-aging services and life extension ... Dr. Ivan de Weber, a ... co-founder of both Inneova(TM) and DNArtistic has,brought together a ...
... High School Student Volunteers Collaborate in Musical Production , ... HAWTHORNE, N.J., Dec. 15 Sharing The ... organization and conservatory bringing together individuals with mild to ... to announce that its members, all children and teens ...
Cached Medicine News:Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 2Health News:US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 3Health News:US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 4Health News:Obesity-Related Hormone Tied to Psoriasis 2Health News:DNA Jewel to Finance Anti-Aging Services & Cancer Research 2Health News:Sharing The Arts & Ridgewood High School Present Musical Production of Charlie and The Chocolate Factory 2
Key periosteal elevators, blade width 1" (25 mm), total length 7 1/2" (191 mm)....
Hoen periosteal elevators, No.3, blade width 3/4" (20 mm), total length 7 1/2" (191 mm)....
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm)....
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Medicine Products: